Literature DB >> 24699985

Metastatic gastric MALT lymphoma masquerading as pulmonary infiltrates, with a dramatic response to chemotherapy.

Sami Samiullah1, Hadi Bhurgri, Madiha Tufail, Fatima Samad, Sheenal Patel, Marium Marium, Lillian Pliner, Zamir Brelvi, Weizheng Wang.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24699985     DOI： 10.1007/s12029-014-9606-y

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  22 in total

1.  Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy.

Authors:  Giovanni Martinelli; Daniele Laszlo; Andrés J M Ferreri; Giancarlo Pruneri; Maurilio Ponzoni; Annarita Conconi; Cristiano Crosta; Ennio Pedrinis; Francesco Bertoni; Liliana Calabrese; Emanuele Zucca
Journal:  J Clin Oncol       Date:  2005-01-24       Impact factor: 44.544

2.  Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study.

Authors:  Sung Yong Oh; Won Seog Kim; Jin Seok Kim; Seok Jin Kim; Hyuk-Chan Kwon; Dae Ho Lee; Jong Ho Won; In Gyu Hwang; Min Kyoung Kim; Soon Il Lee; Yee Soo Chae; Deok-Hwan Yang; Gyeong-Won Lee; Chul Won Choi; Jinny Park; Cheolwon Suh; Hyo-Jin Kim
Journal:  Ann Hematol       Date:  2009-12-19       Impact factor: 3.673

3.  Role of radiation therapy in the treatment of stage I/II mucosa-associated lymphoid tissue lymphoma.

Authors:  H K Tsai; S Li; A K Ng; B Silver; M A Stevenson; P M Mauch
Journal:  Ann Oncol       Date:  2007-01-11       Impact factor: 32.976

4.  Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients.

Authors:  C Thieblemont; Y Bastion; F Berger; C Rieux; G Salles; C Dumontet; P Felman; B Coiffier
Journal:  J Clin Oncol       Date:  1997-04       Impact factor: 44.544

5.  Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma.

Authors:  A C Wotherspoon; C Ortiz-Hidalgo; M R Falzon; P G Isaacson
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

6.  Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.

Authors:  Adam J Olszewski; Jorge J Castillo
Journal:  Cancer       Date:  2012-08-14       Impact factor: 6.860

7.  Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.

Authors:  Emanuele Zucca; Annarita Conconi; Ennio Pedrinis; Sergio Cortelazzo; Teresio Motta; Mary K Gospodarowicz; Bruce J Patterson; Andrés J M Ferreri; Maurilio Ponzoni; Liliana Devizzi; Roberto Giardini; Graziella Pinotti; Carlo Capella; Pier Luigi Zinzani; Stefano Pileri; Armando López-Guillermo; Elias Campo; Achille Ambrosetti; Luca Baldini; Franco Cavalli
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

8.  Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept.

Authors:  B G Taal; H Boot; P van Heerde; D de Jong; A A Hart; J M Burgers
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

9.  The difference in NK-cell activity between patients with non-Hodgkin's lymphomas and Hodgkin's disease.

Authors:  G Konjević; V Jurisić; B Banićevic; I Spuzić
Journal:  Br J Haematol       Date:  1999-01       Impact factor: 6.998

Review 10.  Gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Asyia Ahmad; Yogesh Govil; Barbara B Frank
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.